CODX Co-Diagnostics, Inc.
Company Analysis
Latest News
Co-Diagnostics Cancels 2026 Annual Meeting After Failing to Reach Quorum
Co-Diagnostics, Inc. has canceled its 2026 Annual Meeting of Stockholders after failing to achieve the required quorum on four separate occasions. The company...
Co-Diagnostics Enters Senior Secured Convertible Loan Agreement for Up to $3.1 Million
Co-Diagnostics, Inc. has entered into a loan agreement with J.J. Astor & Co. for senior secured convertible loans totaling up to $3.1 million. The initial...
Co-Diagnostics Collaborates with ReadyGo on Blood-Based Point-of-Need PCR Testing
Co-Diagnostics, Inc. (CODX) announced a collaboration with UK-based ReadyGo Diagnostics Ltd. to evaluate the use of ReadyGo's sample-preparation technology...
Co-Diagnostics Announces CFO Transition, Appoints Daniel Bohrer as Successor
Co-Diagnostics, Inc. announced the departure of Chief Financial Officer Brian Brown and the immediate appointment of Daniel Bohrer as the company's new...
Co-Diagnostics second quarter 2026 revenue of $0.17M beat estimates as FDA submission was filed
Co-Diagnostics reported second quarter 2026 revenue of $0.17 million, outperforming the $0.13 million consensus estimate. The company’s net loss narrowed to...
Co-Diagnostics, Inc. Q2 2026 Earnings Preview: What Analysts Expect on August 13, 2026
Analysts expect Co-Diagnostics, Inc. to report a Q2 2026 consensus revenue of approximately $0.13 million and an EPS loss of $3.00, while the stock currently...
Co-Diagnostics to Raise $2.67M Through Warrant Inducement Agreement
Co-Diagnostics, Inc. has entered into an inducement agreement with certain warrant holders to exercise their existing warrants for cash. The transaction is...
🔴 Co-Diagnostics, Inc. is trading 10.5% down today as S-3 resale registration fuels dilution concerns
Co-Diagnostics, Inc. is trading 10.5% down today at $5.57 as traders react to an S-3 resale registration enabling the sale of up to 4.94 million shares and...
🔴 Co-Diagnostics, Inc. is trading 5.5% down today as volatility persists following S-3 resale registration
Co-Diagnostics, Inc. is trading 5.5% down at $5.88 in pre-market, extending sharp volatility following an S-3 resale registration filing. • Shares have...
🟢 Co-Diagnostics, Inc. is trading 19.7% up today, rebounding from a steep selloff tied to a resale registration filing
Co-Diagnostics, Inc. is trading at $7.42 (up 19.7%) today, rebounding after a sharp decline triggered by a large resale registration filing. • Shares fell...
Co-Diagnostics Plummets 21% Following 5 Million Share Resale Filing
Co-Diagnostics (CODX) shares dropped approximately 21% during early trading on Monday. The stock price fell to $6.71 following a Securities and Exchange...
🔴 Co-Diagnostics, Inc. is trading 20.3% down today as speculative Ebola-driven gains continue to unwind
Co-Diagnostics, Inc. is trading 20.3% down at $6.80 as traders continue to unwind positions following last week’s extreme Ebola-driven surge and subsequent...
🟢 CODX is trading 12.2% up today as shares stabilize following extreme Ebola-driven volatility
CODX is trading 12.2% up at $9.57 as shares attempt to stabilize following a period of extreme volatility and a sharp pullback from recent highs. • The move...
CODX Rode an Ebola Scare From $1.50 to $11 — Can a Company With $146K in Revenue Hold That Ground?
Shares of Co-Diagnostics are stabilizing at $8.73 in pre-market Monday, up 2.3%, as the micro-cap diagnostics maker tries to find a floor after one of 2026's...
Co-Diagnostics Shares Sink 24%, Ending 630% Rally on Ebola Test News
Shares of Co-Diagnostics, Inc. (CODX) fell over 24% on May 29, 2026. Investors initiated profit-taking following an extraordinary market rally. The stock...
🟢 CODX is trading 14.39% up today, extending a massive multi-session momentum surge
CODX is trading at $12.80 (14.39% up) as it continues to extend a powerful multi-day rally despite a lack of fresh company-specific news or regulatory...